邻苯二甲酸酯暴露与2型糖尿病患者白蛋白尿相关:横断面研究
结果显示MEHP和MEOHP暴露与白蛋白尿程度独立相关,与eGFR无关。
要点
- MEHP和MEOHP最高四分位暴露者白蛋白尿风险显著增加。
- 尿代谢物水平与eGFR无关,提示其独立于肾功能。
- MEOHP在心血管事件患者中较高,MEHP呈阳性趋势。
核心结论
- 邻苯二甲酸二乙基己酯代谢物暴露与糖尿病患者白蛋白尿程度相关。
- 尿代谢物水平与eGFR无关,提示其独立于肾功能。
研究设计与样本
- 检测晨尿中三种邻苯二甲酸二乙基己酯代谢物,经肌酐校正,并调整混杂因素。
主要发现
- MEHP、MEOHP和MEHHP经肌酐校正的尿浓度分别为7.53 µg/g(范围4.84-12.60)、3.04 µg/g(范围1.03-5.14)和10.70 µg/g(范围7.02-17.40)。
- 微量/大量白蛋白尿患者MEHP(P=0.0173)和MEOHP(P=0.0306)暴露更高。
- 最高四分位与最低四分位相比,白蛋白尿风险增加:MEHP OR=4.83(95%CI 1.45-16.06,P=0.0297);MEOHP OR=3.29(95%CI 1.08-10.04,P=0.0352)。
- 有心血管事件者MEOHP更高(P=0.034),MEHP呈阳性趋势(P=0.061)。
临床怎么用
- 在糖尿病患者中,可关注邻苯二甲酸酯暴露作为白蛋白尿的潜在相关因素。
- 尿代谢物水平与eGFR无关,解读时需结合肾功能分期。
局限性
- 横断面设计无法推断因果关系。
- 单次尿样可能无法反映长期暴露。
- 样本为连续就诊患者,外推性受限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Recent epidemiological observations have reported an association among phthalates exposure and insulin resistance, obesity, and diabetes but have not related exposure to these environmental pollutants with microvascular complications of diabetes. OBJECTIVE: To explore the relationship between phthalates and renal function in subjects with diabetes. DESIGN: Cross-sectional, case-only study. Concentrations of three urinary metabolites of di-2-ethylhexylphthalate were quantified in a spot morning urine sample, normalized for creatinine urinary excretion, and related to clinical parameters and phenotype, adjusting for confounders. PATIENTS: Two hundred and nine patients with diabetes consecutively referred to our clinic. MAIN OUTCOME MEASURES: Relationship between phthalates and renal function [evaluated with estimated glomerular filtration rate (eGFR) and albuminuria]. RESULTS: Creatinine-adjusted urinary concentrations of mono-2-ethylhexyl phthalate (MEHP), mono-2-ethyl-5-oxohexyl phthalate (MEOHP), and mono-2-ethyl-5-hydroxyhexyl phthalate were 7.53 µg/g (range, 4.84 to 12.60), 3.04 µg/g (range, 1.03 to 5.14), and 10.70 µg/g (7.02 to 17.40), respectively. Age, sex, body mass index, diabetes duration, smoking, blood pressure, glycated Hb, and eGFR did not influence their levels. Exposure to MEHP and MEOHP was greater in individuals with microalbuminuria/macroalbuminuria (MEHP, P = 0.0173; MEOHP, P = 0.0306). The fourth vs first quartile showed a greater risk of albuminuria (MEHP: OR, 4.83; 95% CI, 1.45 to 16.06; P = 0.0297; MEOHP: OR, 3.29; 95% CI, 1.08 to 10.04); P = 0.0352). MEOHP was greater (P = 0.034) in subjects with cardiovascular events; MEHP showed a positive trend (P = 0.061). CONCLUSION: Our findings have revealed an association between exposure to di-2-ethylhexylphthalate metabolites and the degree of albuminuria in subjects with diabetes; the lack of a relationship with eGFR suggests their urinary levels are independent of renal function.
引用
- Mengozzi A, Carli F, Biancalana E, et al. Phthalates Exposure as Determinant of Albuminuria in Subjects With Type 2 Diabetes: A Cross-Sectional Study. J Clin Endocrinol Metab. 2019. PMID: 30462244. doi:10.1210/jc.2018-01797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。